Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

Erik Vegt*, Marion de Jong, Jack F. M. Wetzels, Rosalinde Masereeuw, Marleen Melis, Wim J. G. Oyen, Martin Gotthardt, Otto C. Boerman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1049-1058
JournalJournal of Nuclear Medicine
Volume51
Issue number7
DOIs
Publication statusPublished - 1 Jul 2010

Keywords

  • kidney
  • peptide
  • antibody fragment
  • radionuclide therapy
  • PRRT

Cite this